Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1-Infected Children Aged 2 Through 18 YearsSharon Nachman, H. N. Ndiweni, Naiyu Zheng et al.|Clinical Infectious Diseases|2013Cited by 60
691. Epidemiology of Viral Respiratory Infections in Pediatric Transplant: Initial results from the Viral Infections in Pediatric Transplant Recipients (VIPER) StudyGabriela A. Marón, Janet A Englund, Sarah K Johnson et al.|Open Forum Infectious Diseases|2026Cited by 0